select a format

Single User License
USD 250 INR 16145
Site License
USD 500 INR 32290
Corporate User License
USD 750 INR 48435

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Vascular Biogenics Ltd (VBLT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Vascular Biogenics Ltd (VBLT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH137090D
  • |
  • Pages: 27
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Vascular Biogenics Ltd (VBL) is a biotechnology company that develops treatments for immuno-inflammatory diseases and cancer. The company's product pipeline includes VB-111. Its product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for cancer therapy. VBL also administers treatment for solid tumor indications, with clinical trials in rGBM, thyroid cancer and ovarian cancer. The company designs its product to address oncology indications in solid tumors, by the blood vessels required for tumor growth. It also developed programs based proprietary platform technologies including an oncology program and an anti-inflammatory program. VBL is headquartered in Or Yehuda, Israel.

Vascular Biogenics Ltd (VBLT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Vascular Biogenics Ltd, Medical Devices Deals, 2011 to YTD 2017 9

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Vascular Biogenics Raises USD24 Million in Private Placement of Shares 11

Vascular Biogenics Raises USD15 Million in Public Offering of Shares and Warrants 12

Vascular Biogenics Raises USD40 Million in IPO 13

Vascular Biogenics Ltd-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

Financial Announcements 19

May 15, 2017: VBL Therapeutics Announces First Quarter 2017 Financial Results 19

Aug 15, 2016: VBL Therapeutics Announces Second Quarter 2016 Financial Results and Provides Business Update 21

May 13, 2016: VBL Therapeutics Announces First Quarter 2016 Financial Results and Provides Business Update 22

Mar 29, 2016: VBL Therapeutics Announces Full-Year 2015 Financial Results and Provides Business Update 23

Clinical Trials 25

Apr 03, 2017: VBL Therapeutics Presents New Data Supporting Use of Lecinoxoids in NASH 25

Feb 22, 2016: VBL Therapeutics Announces Launch of the First Israeli Site as Part of the GLOBE International Pivotal Trial for VB-111 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27

List of Figures

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Vascular Biogenics Ltd, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Vascular Biogenics Ltd, Deals By Therapy Area, 2011 to YTD 2017 8

Vascular Biogenics Ltd, Medical Devices Deals, 2011 to YTD 2017 9

Vascular Biogenics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Vascular Biogenics Raises USD24 Million in Private Placement of Shares 11

Vascular Biogenics Raises USD15 Million in Public Offering of Shares and Warrants 12

Vascular Biogenics Raises USD40 Million in IPO 13

Vascular Biogenics Ltd, Key Competitors 16

Vascular Biogenics Ltd, Key Employees 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Vascular Biogenics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com